, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in

appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a

also service station location expansion; there was 1,176 stations at the end of Q1/2019. The Company had used several strategies to increase sales volume through various market promotional program e.g

projects would be from year 2020 onwards. Expansion in Cambodia, the Philippines and Oman B.Grimm has expanded renewable power business to the Philippines through the 6 MW solar rooftop project, to Oman

continues to carry out renovations at existing shopping malls to maximize their operating performances. 2.) CentralPlaza Chonburi, with both locations to undergo leasable area expansion of around 1,000

according to the draft of lease agreement and located on no. 486 Onnut Road (Sukhumvit 77), SuanLuang Sub-District, SuanLuang District, Bangkok .The Company intend to invest in the expansion of its branch

draft of lease agreement and located on no. 486 Onnut Road (Sukhumvit 77), SuanLuang Sub-District, SuanLuang District, Bangkok .The Company intend to invest in the expansion of its branch which the

Limited (CRC) and CPN with 33% stake through Chipper Global Limited. The objective is to invest in Grab businesses in order to enhance channel for business expansion including increase traffic as well as

Equity Capacity COD of projects Selective Growth COD of projects ERU +250MW Rayong WTE +10MW Expansion+18MW +2,771MW COD of projects CUP 4 +45MW NL1PC +26MW CUP 3 Expansion +15MW XPCL +321MW +39.5MW Note